SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Clinical delineation, sex differences, and genotype-phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2.

Faundes, V; Goh, S; Akilapa, R; Bezuidenhout, H; Bjornsson, HT; Bradley, L; Brady, AF; Brischoux-Boucher, E; Brunner, H; Bulk, S; et al. Faundes, V; Goh, S; Akilapa, R; Bezuidenhout, H; Bjornsson, HT; Bradley, L; Brady, AF; Brischoux-Boucher, E; Brunner, H; Bulk, S; Canham, N; Cody, D; Dentici, ML; Digilio, MC; Elmslie, F; Fry, AE; Gill, H; Hurst, J; Johnson, D; Julia, S; Lachlan, K; Lebel, RR; Byler, M; Gershon, E; Lemire, E; Gnazzo, M; Lepri, FR; Marchese, A; McEntagart, M; McGaughran, J; Mizuno, S; Okamoto, N; Rieubland, C; Rodgers, J; Sasaki, E; Scalais, E; Scurr, I; Suri, M; van der Burgt, I; Matsumoto, N; Miyake, N; Benoit, V; Lederer, D; Banka, S (2021) Clinical delineation, sex differences, and genotype-phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2. Genet Med, 23 (7). pp. 1202-1210. ISSN 1530-0366 https://doi.org/10.1038/s41436-021-01119-8
SGUL Authors: Elmslie, Frances

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

PURPOSE: The variant spectrum and the phenotype of X-linked Kabuki syndrome type 2 (KS2) are poorly understood. METHODS: Genetic and clinical details of new and published individuals with pathogenic KDM6A variants were compiled and analyzed. RESULTS: Sixty-one distinct pathogenic KDM6A variants (50 truncating, 11 missense) from 80 patients (34 males, 46 females) were identified. Missense variants clustered in the TRP 2, 3, 7 and Jmj-C domains. Truncating variants were significantly more likely to be de novo. Thirteen individuals had maternally inherited variants and one had a paternally inherited variant. Neonatal feeding difficulties, hypoglycemia, postnatal growth retardation, poor weight gain, motor delay, intellectual disability (ID), microcephaly, congenital heart anomalies, palate defects, renal malformations, strabismus, hearing loss, recurrent infections, hyperinsulinism, seizures, joint hypermobility, and gastroesophageal reflux were frequent clinical findings. Facial features of over a third of patients were not typical for KS. Males were significantly more likely to be born prematurely, have shorter stature, and severe developmental delay/ID. CONCLUSION: We expand the KDM6A variant spectrum and delineate the KS2 phenotype. We demonstrate that the variability of the KS2 phenotypic depends on sex and the variant type. We also highlight the overlaps and differences between the phenotypes of KS2 and KS1.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative CommonsAttribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2021
Keywords: 0604 Genetics, 1103 Clinical Sciences, Genetics & Heredity
Journal or Publication Title: Genet Med
ISSN: 1530-0366
Language: eng
Dates:
DateEvent
July 2021Published
5 March 2021Published Online
3 February 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
629396Kabuki Research FundUNSPECIFIED
72160007National Commission for Scientific and Technological ResearchUNSPECIFIED
HICF-1009-003)Health Innovation Challenge FundUNSPECIFIED
JP20ek0109280Japan Agency for Medical Research and DevelopmentUNSPECIFIED
JP20dm0107090Japan Agency for Medical Research and DevelopmentUNSPECIFIED
JP20ek0109301Japan Agency for Medical Research and DevelopmentUNSPECIFIED
JP20ek0109348Japan Agency for Medical Research and DevelopmentUNSPECIFIED
JP20kk0205012Japan Agency for Medical Research and DevelopmentUNSPECIFIED
JP17H01539JSPS KAKENHIUNSPECIFIED
JP19H06321JSPS KAKENHIUNSPECIFIED
Ministero della SaluteRC2020UNSPECIFIED
PubMed ID: 33674768
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113098
Publisher's version: https://doi.org/10.1038/s41436-021-01119-8

Actions (login required)

Edit Item Edit Item